Home » » Vetter Pharma-Fertigung Launches Major Expansion
Vetter Pharma-Fertigung Launches Major Expansion
PharmaManufacturing.com
06/22/2005
Scheduled for completion by the fall of 2006, Vetter's new state-of-the-art facility will increase its production capacity by more than 30 percent and allow Vetter to broaden its product portfolio. The company is presently capable of producing more than 300 million pre-filled syringe systems per year at its various sites.
Vetter's new facility is being built in the vicinity of the existing production lines. Each location operates independently and can be used at all times as a fully operational back-up facility. By duplicating the production lines, Vetter is providing its customers with considerable delivery and process security. For over 15 years, Vetter’s production facilities have been inspected regularly by international regulatory agencies, including the U.S. Food and Drug Administration and the European Medicines Agency (EMEA), as well as its customers.
Vetter Pharma-Fertigung GmbH & Co. KG has been active as an independent pharmaceutical service partner for more than 50 years. Twenty-five years ago, Vetter began focusing on the aseptic production of liquid and lyophilized drugs. In addition to standard injection systems and cartridges, the company also offers its own administration systems, such as the Vetter Lyo-Ject dual-chamber syringe. Vetter currently has more than 127 patents to its name, including solutions to prevent counterfeiting and piracy. The company offers a variety of services through its three branches: Development Service, for product development from manufacturing to launch; Commerical Manufacturing, for start-to-finish manufacturing operations; and Solutions, which specializes in application systems.
For more information, contact:
Vetter Pharma-Fertigung GmbH & Co. KG
Schützenstraße 87
88212 Ravensburg
Telephone: +49 751 3700 0
Fax: (0751) 37 00-40 00
E-Mail: info@vetter-pharma.com
www.vetter-pharma.com
More News:
- 09/02/2010 SEC Nabs Merck Exec for Insider TradingFrom NYPost.com
- 09/02/2010 PBS: Behind FDA's Resource ChallengeFrom PBS.org
- 08/30/2010 Sanofi CEO: Genzyme is 'Stonewalling'From TheStreet.com
- 08/26/2010 115 Employees at Pfizer Will Lose Jobs in DecemberFrom RecordOnline.com
- 08/26/2010 Mexican Drug Gangs Target Pharma ShipmentsFrom SecuringPharma.com
- 08/26/2010 Lilly Manufacturing Facility Shutting Down, 140 People AffectedFrom MyCentralJersey.com
- 08/25/2010 Rockwell Automation Releases FactoryTalk Pharma Suite 2.1 Software
- 08/24/2010 Recall Fallout: FDA Puts Execs On NoticeFrom Money.CNN.com
- 08/19/2010 Dumped in a Parking Lot: How Pfizer Fires Sales Reps It Doesn't LikeFrom BNet.com
- 08/19/2010 Pharma's Contraction Leads to Outsourcing HiresFrom Portfolio.com
- All news »
More content on this topic:
Get Connected Now!
- Featured White Papers

Print page